Dutch firm gets Fox Foundation funding for PD tech

Dutch drug delivery outfit to-BBB is getting bankrolled by The Michael J. Fox Foundation to support the development of 2B3-201, a drug designed to treat neuroinflammation associated with Parkinson's disease, Genetic Engineering & Biotechnology News reports. The drug uses to-BBB's G-Technology delivery platform, which gets molecules across the blood-brain barrier using drug-loaded liposomes coated with glutathione-conjugated PEG. Report

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

A self-injection pen prefilled with Brussels-based UCB’s Cimzia (certolizumab pegol) has been made available this week in the U.K. after a positive opinion…

Everstone, a private equity firm specializing in India and Southeast Asia, has finally decided to shell out Rs 220 crore ($33 million) to obtain a 70% stake--a…